Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Summary

This study will compare in-person induction and maintenance dosing of sublingual buprenorphine to induction and maintenance dosing of sublingual buprenorphine through comprehensive telehealth sessions and telehealth medication for opioid use disorder (MOUD).

Timeline

Start

2026-06-01

Primary completion

2026-12-31

Completion

2026-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “Due to a federally mandated, institution-wide pause in research activities under the institution's Federal Wide Assurance (FWA) that occurred during the timeline for this study, recruitment was never initiated and no participants were enrolled.”

Drugs

Indications